| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |